Watchlist

•

	Dow	25,146.39	346.41	1.40%
	S&P 500	2,772.35	23.55	0.86%
	Nasdaq	7,689.24	51.38	0.67%
	GlobalDow	3,062.76	27.40	0.90%
	Gold	1,300.90	-1.30	-0.10%
	Oil	65.04	-0.48	-0.73%

S&P 500 Movers(%)

Latest NewsAll Times Eastern

4:18p
Breaking Zscaler shares rise as results, outlook top Street view
4:17p
Breaking Dow books best day in 2 months as Nasdaq logs 3rd straight record close
4:14p
Updated 10-year U.S. government bond yield climbs toward 3% level as eurozone bonds sell off
4:00p
Nasdaq Composite ends at record for third straight session
4:00p
Breaking U.S. stocks end solidly higher as Dow climbs over 300 points
3:54p
Sam Zell on the real estate cycle, interest rates, and immigration
3:55p
Updated Euro hits 2-week high against dollar as ECB indicates readiness to talk QE-unwind timing
3:53p
How to help someone who is struggling with depression
3:41p
Updated Tesla stock surges as shareholders show renewed confidence in CEO Elon Musk
3:31p
Twitter's stock inches toward 10th-straight gain, after erasing earlier sharp losses

|

TNXP U.S.: Nasdaq

Tonix Pharmaceuticals Holding Corp.

Watchlist CreateTNXPAlert

TNXPUSAfter HoursBack To Top

Last Updated: Jun 6, 2018 4:06 p.m. EDT Delayed quote

^$ 4.14

0.13

3.24%

After Hours Volume:

400

Close	Chg	Chg %
$4.01	0.55	15.90%	0.55 15.90%

Advanced Charting

$
%
Vol

Advanced Charting

595.4% vs Avg.

Volume: 409.6K 65 Day Avg. - 68.8K

Open: 3.58

Close: 4.01

3.58 Day Low/High 4.22

Day Range

2.70 52 Week Low/High 4.99

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Create Account … or Log In

	Symbol Company	Price Chg/Chg %

(Go to Your Watchlist)

No Items in Watchlist

There are currently no items in this Watchlist.

Add Tickers

No Saved Watchlists

Create a list of the investments you want to track.

Create Watchlist …or try this starter list

Uh oh

Something went wrong while loading Watchlist.

Go to Watchlist

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Open $3.58
Day Range 3.58 - 4.22
52 Week Range 2.70 - 4.99
Market Cap $29.28M
Shares Outstanding 8.13M
Public Float 7.93M
Beta 0.93
Rev. per Employee n/a
P/E Ratio n/a
EPS $-3.01
Yield n/a
Dividend n/a
Ex-Dividend Date n/a
Short Interest 227.32K 05/15/18
% of Float Shorted 2.87%
Average Volume 68.8K

5 Day	16.91%
1 Month	41.20%
3 Month	10.16%
YTD	16.23%
1 Year	-4.75%

MarketWatch
Other Dow Jones

Tonix Pharmaceuticals started at buy with $8 stock price target at B. Riley FBR

Tonix Pharmaceuticals started at buy with $8 stock price target at B. Riley FBR

Jun. 6, 2018 at 2:06 p.m. ET
by Tomi Kilgore

Tonix Pharma's stock plummets after stock offering prices at deep discount

Jun. 16, 2016 at 8:26 a.m. ET
by Tomi Kilgore

Tonix Pharmaceuticals' stock plunges 18% premarket after stock offering announced late Wednesday

Jun. 16, 2016 at 7:43 a.m. ET
by Tomi Kilgore

10 stocks that are pushing the Nasdaq to 5,000

10 stocks that are pushing the Nasdaq to 5,000

Feb. 23, 2015 at 5:48 p.m. ET
by Philip van Doorn

Keep an Eye on Inflation Data — Morning MoneyBeat

Keep an Eye on Inflation Data — Morning MoneyBeat

Jun. 16, 2016 at 9:19 a.m. ET
on The Wall Street Journal

CFO Moves: Core-Mark, Sprouts Farmers, Tonix Pharmaceuticals

CFO Moves: Core-Mark, Sprouts Farmers, Tonix Pharmaceuticals

Feb. 25, 2016 at 7:46 p.m. ET
on The Wall Street Journal

Stocks to Watch: Intuitive Surgical, Juniper Networks, Microsoft

Jan. 24, 2014 at 9:06 a.m. ET
on The Wall Street Journal

Other News
Press Releases

Premarket analyst action - healthcare

Premarket analyst action - healthcare

Jun. 6, 2018 at 7:57 a.m. ET
on Seeking Alpha

Your Daily Pharma Scoop: ACRX NDA Accepted, BioMarin Gets Approval, Genmab Fails Study

Your Daily Pharma Scoop: ACRX NDA Accepted, BioMarin Gets Approval, Genmab Fails Study

May. 27, 2018 at 7:15 p.m. ET
on Seeking Alpha

Aptinyx readies IPO

Aptinyx readies IPO

May. 24, 2018 at 12:03 p.m. ET
on Seeking Alpha

Tonix Pharma completes pharmacokinetic bridging study for lead candidate Tonmya; shares up 3%

Tonix Pharma completes pharmacokinetic bridging study for lead candidate Tonmya; shares up 3%

May. 24, 2018 at 9:54 a.m. ET
on Seeking Alpha

Oryzon Genomics commences mid-stage study of Alzheimer's candidate

Oryzon Genomics commences mid-stage study of Alzheimer's candidate

May. 14, 2018 at 12:27 p.m. ET
on Seeking Alpha

10-Q: TONIX PHARMACEUTICALS HOLDING CORP.

10-Q: TONIX PHARMACEUTICALS HOLDING CORP.

May. 11, 2018 at 4:12 p.m. ET
on Edgar Online - (EDG = 10Q, 10K)

Tonix Is A Buy For Potentially Great Return On PTSD Breakthrough

Tonix Is A Buy For Potentially Great Return On PTSD Breakthrough

May. 9, 2018 at 11:51 a.m. ET
on Seeking Alpha

Tonix: PTSD Breakthrough Or Too Risky For Stockholders?

Tonix: PTSD Breakthrough Or Too Risky For Stockholders?

May. 7, 2018 at 3:09 p.m. ET
on Seeking Alpha

Tonix on go with mid-stage study of TNX-102 SL in Alzheimer's agitation; shares up 7% premarket

Tonix on go with mid-stage study of TNX-102 SL in Alzheimer's agitation; shares up 7% premarket

May. 1, 2018 at 8:12 a.m. ET
on Seeking Alpha

Tonix Pharmaceuticals (TNXP) Presents At MicroCap Conference 2018 - Slideshow

Tonix Pharmaceuticals (TNXP) Presents At MicroCap Conference 2018 - Slideshow

Apr. 10, 2018 at 12:23 p.m. ET
on Seeking Alpha

Tonix Pharmaceuticals achieves 50% enrollment in Phase 3 trial of Tonmya for the treatment of PTSD

Tonix Pharmaceuticals achieves 50% enrollment in Phase 3 trial of Tonmya for the treatment of PTSD

Apr. 3, 2018 at 8:50 a.m. ET
on Seeking Alpha

10-K: TONIX PHARMACEUTICALS HOLDING CORP.

10-K: TONIX PHARMACEUTICALS HOLDING CORP.

Mar. 9, 2018 at 4:10 p.m. ET
on Edgar Online - (EDG = 10Q, 10K)

Key events next week - healthcare

Key events next week - healthcare

Mar. 9, 2018 at 9:58 a.m. ET
on Seeking Alpha

Key events next week - healthcare

Feb. 9, 2018 at 12:34 p.m. ET
on Seeking Alpha

Key events next week - healthcare

Jan. 26, 2018 at 8:01 a.m. ET
on Seeking Alpha

Premarket Gainers as of 9:05 am (1/23/2018)

Jan. 23, 2018 at 9:24 a.m. ET
on Seeking Alpha

Tonix Pharmaceuticals receives notice of allowance for new U.S. patent for the active ingredient in Tonmya

Jan. 23, 2018 at 8:30 a.m. ET
on Seeking Alpha

Tonix Pharmaceuticals (TNXP) Presents At 10th Annual Biotech Showcase 2018 - Slideshow

Jan. 10, 2018 at 1:38 p.m. ET
on Seeking Alpha

Your Daily Pharma Scoop: Heron Enters 2018 On Strong Note, Teva Launches Generic Reyataz, Sarepta Top Smid-Cap Pick

Dec. 29, 2017 at 1:58 a.m. ET
on Seeking Alpha

Your Daily Pharma Scoop: Amgen Plans To Bring Back Cash, Roche Acquires Ignyta, Agile Tumbles On CRL

Dec. 26, 2017 at 4:23 a.m. ET
on Seeking Alpha

Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from the Phase 2 AtEase Study at the American Society of Clinical Psychopharmacology

Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from the Phase 2 AtEase Study at the American Society of Clinical Psychopharmacology

May. 31, 2018 at 4:31 p.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at the 2018 BIO International Convention

Tonix Pharmaceuticals to Present at the 2018 BIO International Convention

May. 30, 2018 at 8:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Reports Preliminary Results from a Phase 1 Pivotal Multiple-Dose Bridging Pharmacokinetic (PK) Study of Tonmya(R) or TNX-102 SL

Tonix Pharmaceuticals Reports Preliminary Results from a Phase 1 Pivotal Multiple-Dose Bridging Pharmacokinetic (PK) Study of Tonmya(R) or TNX-102 SL

May. 24, 2018 at 7:00 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at the 2018 American Society of Clinical Psychopharmacology

Tonix Pharmaceuticals to Present at the 2018 American Society of Clinical Psychopharmacology

May. 23, 2018 at 4:05 p.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at the BIO KOREA 2018 International Convention

Tonix Pharmaceuticals to Present at the BIO KOREA 2018 International Convention

May. 7, 2018 at 7:00 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Receives IND Clearance by U.S. FDA for TNX-102 SL in Agitation in Alzheimer's Disease

Tonix Pharmaceuticals Receives IND Clearance by U.S. FDA for TNX-102 SL in Agitation in Alzheimer's Disease

May. 1, 2018 at 7:01 a.m. ET
on GlobeNewswire

Eyenovia Appoints Three Industry Veterans to Board of Directors

Eyenovia Appoints Three Industry Veterans to Board of Directors

Mar. 26, 2018 at 4:05 p.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

Tonix Pharmaceuticals to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

Mar. 13, 2018 at 7:00 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Programs Update

Mar. 12, 2018 at 7:51 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at the 30th Annual ROTH Conference

Mar. 6, 2018 at 7:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Appoints David L. Grange to the Board of Directors

Feb. 15, 2018 at 7:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at the 20th Annual BIO CEO & Investor Conference in New York City

Feb. 7, 2018 at 4:31 p.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at Noble Capital Markets' Fourteenth Annual Investor Conference in Fort Lauderdale

Jan. 24, 2018 at 4:31 p.m. ET
on GlobeNewswire

Blog Exposure - Tonix Declares Publication of Research about Potential Smallpox-Preventing Vaccine Candidate TNX-801

Jan. 23, 2018 at 7:22 a.m. ET
on ACCESSWIRE

Tonix Pharmaceuticals Receives Notice of Allowance for New U.S. Patent for the Active Ingredient in Tonmya(R) (Cyclobenzaprine HCl Sublingual Tablets)

Jan. 23, 2018 at 7:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Announces Publication Reporting Synthesis, Construction and Characterization of a Potential Smallpox-Preventing Vaccine Candidate TNX-801 (Live Horsepox Virus from Cell Culture)

Jan. 19, 2018 at 2:01 p.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Appoints Jessica Morris as Chief Operating Officer

Jan. 9, 2018 at 7:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at Sachs Associates Neuroscience Innovation Forum and Biotech Showcase 2018 in San Francisco

Jan. 3, 2018 at 7:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Completes Positive Pre-IND Meeting with FDA for TNX-102 SL (Cyclobenzaprine HCI Sublingual Tablets) as a Clinical Candidate for Agitation in Alzheimer's Disease

Dec. 12, 2017 at 7:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals to Present at 10th Annual LD Micro Investor Conference

Nov. 30, 2017 at 7:01 a.m. ET
on GlobeNewswire

Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 3 Full Ratings

Benzinga's Top Upgrades, Downgrades For August 18, 2017

Aug. 18, 2017 at 9:19 a.m. ET
on Benzinga.com

7 Biggest Price Target Changes For Wednesday

Sep. 7, 2016 at 9:48 a.m. ET
on Benzinga.com

Benzinga's Top Downgrades

Sep. 7, 2016 at 9:03 a.m. ET
on Benzinga.com

Name	Chg %	Market Cap
ArQule Inc.	11.15%	$496.57M
Supernus Pharmaceuticals Inc.	-0.82%	$2.86B
Perrigo Co. PLC	-1.07%	$10.25B
Agile Therapeutics Inc.	-0.31%	$20.87M

Competitor Data Provided By